Reshma A. Merchant1, M. Izquierdo2,3, J. Woo4, J.E. Morley5
1. Division of Geriatric Medicine, Department of Medicine, National University Hospital, and Department of Medicine, Yong Loo Lin School of Medicine, 1E Kent Ridge Rd., NUHS Tower Block Level 10, Singapore, 19228 Singapore; 2. Navarrabiomed, Complejo Hospitalario de Navarra (CHN)- Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain;
3. CIBER of Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain; 4. Jockey Club Institute of Ageing, The Chinese University of Hong Kong, Hong Kong, SAR, China and Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, China; 5. Department of Medicine, Division of Geriatric Medicine, Saint Louis University School of Medicine, 1008 S. Spring Ave., 2nd Floor, St. Louis, Missouri 63110 USA
Corresponding Author: Dr Reshma A Merchant, Division of Geriatric Medicine. Department of Medicine, 1E Kent Ridge Road, NUHS Tower Block, Singapore 119228.
Email: reshmaa@nuhs.edu.sg, ORCID iD: 0000-0002-9032-0184
J Frailty Aging 2022;11(4)339-341
Published online October 24, 2022, http://dx.doi.org/10.14283/jfa.2022.61
The term “resilience” has existed for many decades and defines the ability to bounce back after a stressful encounter or adversity in life (1). Resilience in older adults has gained increasing attention in recent years, and many countries are trying to build resilience at individual, community, and system levels, especially after the Covid-19 pandemic (2, 3). Resilience is dynamic and multidimensional, frequently distinguished into physical resilience and psychological (mental and/or cognitive) resilience (4, 5). Physical resilience is defined as “the ability to recover or optimize function in the face of age-related losses or disease” and is one of the top research priorities for the US National Institute on Aging (1, 6, 7). Declining resilience is considered a marker of accelerated aging and a risk factor for incident frailty. It is associated with adverse functional outcomes in later life. There are multiple risk and protective factors described with the mnemonic “PURPOSE OF LIFE” (Figure 1) (8).
Due to its dynamic and multidimensional nature, resilience is a difficult construct to measure (6, 8, 9). There is no mechanism in place to predict dose-response and tipping point for adverse outcomes (10). The response to stress and recovery is unpredictable due to the co-occurrence of chronic diseases and age-related declines in multiple physiological systems. A stressor can act alone (e.g., bedrest causing muscle wasting and delirium) or in combination with other multiple factors (e.g., osteoarthritis, sedatives and antihypertensives causing falls and fractures) in the onset of adverse outcomes. In addition, aging and resilience trajectories are determined by multiple interacting factors (including environment, exposure to toxins across lifespan, comorbidities, polypharmacy, genetics, lifestyle), all of which contribute to immune-senescence and decline in physical and biological reserves (11, 12). A recent study described four distinct trajectories of recovery in nursing home residents admitted to the emergency department, where those with good baseline function had better post-discharge functional recovery (13). Static evaluations, such as disease burden, geriatric assessment, frailty, gait speed and/or handgrip strength, may predict adverse outcomes but not sufficiently the capacity to recover. Multiple longitudinal assessments across the health trajectory may better estimate such capacity (9, 10). While it may be easier to measure physical resilience, this is often inseparable in real life from psychological resilience. To date, there is no scoring system incorporating both measures (14).
Adaptations to adversity are influenced by age, gender, ethnicity, generation differences, cultural variation, type and intensity of the stressor, and intended outcome (15-17). The New Mexico Aging Process Study focused on chronological age where the rate of decline in walking speed and cognition was much higher, and recovery was much lower in the old-old compared with the young-old (18). Age-related changes occur at the cellular, physiological system, and clinical level. A decline in resilience is possibly mediated through the dysregulated immune system, insulin resistance, mitochondrial dysfunction, impaired autophagy and endoplasmic reticulum stress, epigenetics, autonomic and vascular dysfunction (11, 19, 20). Similar dysfunction contributes to the development of frailty syndrome. One may argue that changes at the cellular level may be general changes with aging and not specific to physical resilience as a clinical phenotype (21). There are emerging studies exploring the contribution of biological mechanisms of aging to resilience trajectory in older adults. Higher Growth Differentiation Factor-15 and Tumor Necrosis Factor Receptor-1 levels are associated with frailty, decline in intrinsic capacity, mitochondrial dysfunction, and poor recovery after acute illness (20, 22, 23). In a group of patients with hip fracture, 27% of the differences in physical resilience or expected differential recovery could be explained by biomarkers (24). Various ongoing trials evaluate geroscience-based interventions, including pharmacotherapy and vaccinations on resilience trajectory (such as metformin, resveratrol, omega-3, senolytics – e.g., Dasatinib and Quertin, and low-dose mammalian Target of Rapamycin [mTOR] inhibitors) (25-28).
Frailty is a state of declining physiological reserves, and physical resilience can be described as the ability to mobilize reserves. While static measures, such as gait speed and handgrip strength can be used as a surrogate for underlying reserve, the intrinsic capacity framework proposed by the World Health Organization (WHO; including the assessment of cognition, vitality, mobility, psychological and sensory functions) has shown to predict functional recovery after exposure to adversity (29, 30). Intrinsic capacity can be considered an indirect measure of physical resilience through the physiologic reserve concept (31). The INSPIRE integrated care for older people (ICOPE)-CARE program conducted by the Gerontopole in Toulouse has recently introduced screening for intrinsic capacity using the ICOPE monitor and ICOPEBOT conversational robot with the aim of identifying high-risk older adults (32). Many countries are implementing programs such as frailty screening and multidomain interventions, incorporating nutrition and exercise at individual, community, and city levels to reverse, prevent, or delay the decline in physiological reserves, possibly improving resilience over the long term (33-38).
Incorporating resilience into the prognostication of hospitalized older patients is another evolving research area. Being able to measure baseline resilience, its magnitude, the type of stress (e.g., anesthesia or chemotherapy), the recovery trajectory, and predicting adverse outcomes will enable clinicians to provide cost-effective, personalized care. PRIME-KNEE is an ongoing prospective cohort study for elective knee replacement surgery where pre-stressor static and provocative tests will be validated, and the utility of biomarkers in predicting recovery will be measured (39).
Exercise and physical activity offer clinical benefits as a preventive strategy across a wide range of diseases and disabilities; improvement of muscular function, mental health, and quality of life; and reduction in mortality, with no upper age limit. Similarly, multicomponent exercise intervention programs, especially if including a cognitive task, effectively improve the hallmarks of frailty (i.e., low body mass, weakness, poor mobility, sedentariness, anergia) and cognition, thus optimising functional capacity (40-43). In older adults, the potential role of tailored physical exercise programs to maximize exercise-related effects on the ability to perform activities of daily living or promote resilience should also be explored. An individualized multicomponent exercise training program for older adults (VIVIFRAIL) (http://vivifrail.com/resources/) (44, 45) has shown to partially reverse sarcopenia and frailty (46-48) as well as loss in activities of daily living (i.e., toileting, transfers, mobility, and stair climbing), frequently occurring during and after hospitalisation (49).
In this issue of the Journal of Frailty and Aging, Cesari et al. provide a perspective from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force meeting on the biological and clinical significance of resilience in older adults. The authors have highlighted the challenges in measuring resilience due to its dynamic nature encompassing socioeconomic, environmental, clinical, and biological factors. Preliminary results of ongoing studies are also presented in the paper. It is discussed that future research is needed to develop appropriate tests of resilience in animal models within an aging context. However, the translation to human resilience trajectory may be challenging due to differences in life expectancy and difficulties in replicating the psychological, social, and physical environment, service provisions, and the whole host of social determinants of health throughout the life course. The authors concluded that future research should focus on identifying and validating biomarkers for different resilience phenotypes and developing prevention strategies before the onset of adverse events.
Conflicts of Interest: No conflict of interest.
References
1. Hadley EC, Kuchel GA, Newman AB, Allore HG, Bartley JM, Bergeman CS, et al. Report: NIA Workshop on Measures of Physiologic Resiliencies in Human Aging. The Journals of Gerontology: Series A. 2017;72(7):980-90. doi: 10.1093/gerona/glx015.
2. Yip W, Ge L, Ho AHY, Heng BH, Tan WS. Building community resilience beyond COVID-19: The Singapore way. Lancet Reg Health West Pac. 2021;7:100091. doi: 10.1016/j.lanwpc.2020.100091.
3. Majnarić LT, Bosnić Z, Guljaš S, Vučić D, Kurevija T, Volarić M, et al. Low Psychological Resilience in Older Individuals: An Association with Increased Inflammation, Oxidative Stress and the Presence of Chronic Medical Conditions. Int J Mol Sci. 2021;22(16). doi: 10.3390/ijms22168970.
4. Windle G, Markland DA, Woods RT. Examination of a theoretical model of psychological resilience in older age. Aging Ment Health. 2008;12(3):285-92. doi: 10.1080/13607860802120763.
5. Whitson HE, Cohen HJ, Schmader KE, Morey MC, Kuchel G, Colon-Emeric CS. Physical Resilience: Not Simply the Opposite of Frailty. Journal of the American Geriatrics Society. 2018;66(8):1459-61. doi: 10.1111/jgs.15233.
6. Whitson HE, Duan-Porter W, Schmader KE, Morey MC, Cohen HJ, Colón-Emeric CS. Physical resilience in older adults: systematic review and development of an emerging construct. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 2016;71(4):489-95.
7. Resnick B, Galik E, Dorsey S, Scheve A, Gutkin S. Reliability and Validity Testing of the Physical Resilience Measure. The Gerontologist. 2011;51(5):643-52. doi: 10.1093/geront/gnr016.
8. Merchant RA, Aprahamian I, Woo J, Vellas B, Morley JE. Resilience And Successful Aging. The journal of nutrition, health & aging. 2022;26(7):652-6. doi: 10.1007/s12603-022-1818-4.
9. Pedone C, Costanzo L, Finamore P, Bandinelli S, Ferrucci L, Antonelli Incalzi R. Defining Resilience in Older People: Does a Subjective Definition of Stressor Work? The Journals of Gerontology: Series A. 2021;76(8):1480-5. doi: 10.1093/gerona/glaa189.
10. Olde Rikkert MG, Melis RJ. Rerouting geriatric medicine by complementing static frailty measures with dynamic resilience indicators of recovery potential. Frontiers in Physiology. 2019;10:723.
11. Banić M, Pleško S, Urek M, Babić Ž, Kardum D. Immunosenescence, Inflammaging and Resilience: An Evolutionary Perspective of Adaptation in the Light of COVID-19 Pandemic. Psychiatr Danub. 2021;33(Suppl 4):427-31.
12. Fried LP, Cohen AA, Xue Q-L, Walston J, Bandeen-Roche K, Varadhan R. The physical frailty syndrome as a transition from homeostatic symphony to cacophony. Nature Aging. 2021;1(1):36-46. doi: 10.1038/s43587-020-00017-z.
13. Guion V, De Souto Barreto P, Rolland Y. Nursing Home Residents’ Functional Trajectories and Mortality After a Transfer to the Emergency Department. Journal of the American Medical Directors Association. 2021;22(2):393-8.e3. doi: https://doi.org/10.1016/j.jamda.2020.05.033.
14. Lim KK, Matchar DB, Tan CS, Yeo W, Østbye T, Howe TS, et al. The Association Between Psychological Resilience and Physical Function Among Older Adults With Hip Fracture Surgery. J Am Med Dir Assoc. 2020;21(2):260-6.e2. doi: 10.1016/j.jamda.2019.07.005.
15. Cosco TD, Kaushal A, Hardy R, Richards M, Kuh D, Stafford M. Operationalising resilience in longitudinal studies: a systematic review of methodological approaches. J Epidemiol Community Health. 2017;71(1):98-104.
16. Hirani S, Lasiuk G, Hegadoren K. The intersection of gender and resilience. J Psychiatr Ment Health Nurs. 2016;23(6-7):455-67. doi: 10.1111/jpm.12313.
17. Cosco TD, Kaushal A, Richards M, Kuh D, Stafford M. Resilience measurement in later life: a systematic review and psychometric analysis. Health Qual Life Outcomes. 2016;14:16. doi: 10.1186/s12955-016-0418-6.
18. Qualls C, Waters DL, Vellas B, Villareal DT, Garry PJ, Gallini A, et al. Reversible states of physical and/or cognitive dysfunction: A 9-year longitudinal study. The journal of nutrition, health & aging. 2017;21(3):271-5. doi: 10.1007/s12603-017-0878-3.
19. Ferrucci L, Gonzalez-Freire M, Fabbri E, Simonsick E, Tanaka T, Moore Z, et al. Measuring biological aging in humans: A quest. Aging Cell. 2020;19(2):e13080. doi: 10.1111/acel.13080.
20. Ryan M, Ryznar R. The Molecular Basis of Resilience: A Narrative Review. Frontiers in Psychiatry. 2022;13. doi: 10.3389/fpsyt.2022.856998.
21. Fried LP. Interventions for Human Frailty: Physical Activity as a Model. Cold Spring Harbor Perspectives in Medicine. 2016;6(6). doi: 10.1101/cshperspect.a025916.
22. Tavenier J, Rasmussen LJH, Andersen AL, Houlind MB, Langkilde A, Andersen O, et al. Association of GDF15 With Inflammation and Physical Function During Aging and Recovery After Acute Hospitalization: A Longitudinal Study of Older Patients and Age-Matched Controls. J Gerontol A Biol Sci Med Sci. 2021;76(6):964-74. doi: 10.1093/gerona/glab011.
23. Gonçalves RSdSA, Maciel ÁCC, Rolland Y, Vellas B, de Souto Barreto P. Frailty biomarkers under the perspective of geroscience: a narrative review. Ageing Research Reviews. 2022:101737.
24. Parker DC, Colόn-Emeric C, Huebner JL, Chou C-H, Kraus VB, Pieper CF, et al. Biomarkers Associated with Physical Resilience After Hip Fracture. The Journals of Gerontology: Series A. 2020;75(10):e166-e72. doi: 10.1093/gerona/glaa119.
25. Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288(5):518-36. doi: 10.1111/joim.13141.
26. Anton SD, Cruz-Almeida Y, Singh A, Alpert J, Bensadon B, Cabrera M, et al. Innovations in Geroscience to enhance mobility in older adults. Exp Gerontol. 2020;142:111123. doi: 10.1016/j.exger.2020.111123.
27. Fielding RA. Editorial: Sarcopenia, Frailty, and Gero-science: A Decade of Progress and a Bright Future of Discovery. J Frailty Aging. 2021;10(2):82-3. doi: 10.14283/jfa.2020.37.
28. Weichhart T. mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review. Gerontology. 2018;64(2):127-34. doi: 10.1159/000484629.
29. WHO: Ageing and Health 2021 [Available from: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health.
30. Gijzel SMW, Rector J, van Meulen FB, van der Loeff RS, van de Leemput IA, Scheffer M, et al. Measurement of Dynamical Resilience Indicators Improves the Prediction of Recovery Following Hospitalization in Older Adults. J Am Med Dir Assoc. 2020;21(4):525-30.e4. doi: 10.1016/j.jamda.2019.10.011.
31. Woo J. Frailty, Successful Aging, Resilience, and Intrinsic Capacity: a Cross-disciplinary Discourse of the Aging Process. Current Geriatrics Reports. 2019;8(2):67-71. doi: 10.1007/s13670-019-0276-2.
32. Tavassoli N, de Souto Barreto P, Berbon C, Mathieu C, de Kerimel J, Lafont C, et al. Implementation of the WHO integrated care for older people (ICOPE) programme in clinical practice: a prospective study. Lancet Healthy Longev. 2022;3(6):e394-e404. doi: 10.1016/s2666-7568(22)00097-6.
33. Pilot Health District in Queenstown to focus on residents’ holistic well-being 2021 [Available from: https://news.nus.edu.sg/pilot-health-district-in-queenstown-to-focus-on-residents-holistic-well-being/.
34. Lundy J, Hayden D, Pyland S, Berg-Weger M, Malmstrom TK, Morley JE. An Age-Friendly Health System. J Am Geriatr Soc. 2021;69(3):806-12. doi: 10.1111/jgs.16959.
35. Merchant RA, Tsoi CT, Tan WM, Lau W, Sandrasageran S, Arai H. Community-Based Peer-Led Intervention for Healthy Ageing and Evaluation of the ‘HAPPY’ Program. J Nutr Health Aging. 2021;25(4):520-7. doi: 10.1007/s12603-021-1606-6.
36. Tavassoli N, Piau A, Berbon C, De Kerimel J, Lafont C, De Souto Barreto P, et al. Framework Implementation of the INSPIRE ICOPE-CARE Program in Collaboration with the World Health Organization (WHO) in the Occitania Region. J Frailty Aging. 2021;10(2):103-9. doi: 10.14283/jfa.2020.26.
37. Yu R, Tong C, Woo J. Effect of an integrated care model for pre-frail and frail older people living in community. Age and Ageing. 2020;49(6):1048-55. doi: 10.1093/ageing/afaa087.
38. Merchant RA, Hui RJY, Kwek SC, Sundram M, Tay A, Jayasundram J, et al. Rapid Geriatric Assessment Using Mobile App in Primary Care: Prevalence of Geriatric Syndromes and Review of Its Feasibility. Frontiers in medicine. 2020;7:261-. doi: 10.3389/fmed.2020.00261.
39. Whitson HE, Crabtree D, Pieper CF, Ha C, Au S, Berger M, et al. A template for physical resilience research in older adults: Methods of the PRIME-KNEE study. Journal of the American Geriatrics Society. 2021;69(11):3232-41.
40. Izquierdo M, Duque G, Morley JE. Physical activity guidelines for older people: knowledge gaps and future directions. Lancet Healthy Longev. 2021;2(6):e380-e3. doi: 10.1016/s2666-7568(21)00079-9.
41. Izquierdo M, Merchant RA, Morley JE, Anker SD, Aprahamian I, Arai H, et al. International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines. J Nutr Health Aging. 2021;25(7):824-53. doi: 10.1007/s12603-021-1665-8.
42. Sáez de Asteasu ML, Martínez-Velilla N, Zambom-Ferraresi F, Casas-Herrero Á, Cadore EL, Galbete A, et al. Assessing the impact of physical exercise on cognitive function in older medical patients during acute hospitalization: Secondary analysis of a randomized trial. PLoS Med. 2019;16(7):e1002852. doi: 10.1371/journal.pmed.1002852.
43. Merchant RA, Chan YH, Hui RJY, Tsoi CT, Kwek SC, Tan WM, et al. Motoric cognitive risk syndrome, physio-cognitive decline syndrome, cognitive frailty and reversibility with dual-task exercise. Experimental Gerontology. 2021;150:111362. doi: https://doi.org/10.1016/j.exger.2021.111362.
44. Izquierdo M. Multicomponent physical exercise program VIVIFRAIL [Internet]: Exercise wheels by functional level type. Available at: http://vivifrail.com/resources (Accessed 16th October 2022).
45. Izquierdo M, Rodriguez-Mañas L, Sinclair AJ, Vivifrail Investigators G. What is new in exercise regimes for frail older people — How does the Erasmus Vivifrail Project take us forward? The journal of nutrition, health & aging. 2016;20(7):736-7. doi: 10.1007/s12603-016-0702-5.
46. Martínez-Velilla N, Abizanda P, Gómez-Pavón J, Zambom-Ferraresi F, Sáez de Asteasu ML, Fiatarone Singh M, et al. Effect of an Exercise Intervention on Functional Decline in Very Old Patients During Acute Hospitalizations: Results of a Multicenter, Randomized Clinical Trial. JAMA Intern Med. 2022;182(3):345-7. doi: 10.1001/jamainternmed.2021.7654.
47. Courel-Ibáñez J, Pallarés JG, García-Conesa S, Buendía-Romero Á, Martínez-Cava A, Izquierdo M. Supervised Exercise (Vivifrail) Protects Institutionalized Older Adults Against Severe Functional Decline After 14 Weeks of COVID Confinement. J Am Med Dir Assoc. 2021;22(1):217-9.e2. doi: 10.1016/j.jamda.2020.11.007.
48. Casas-Herrero Á, Sáez de Asteasu ML, Antón-Rodrigo I, Sánchez-Sánchez JL, Montero-Odasso M, Marín-Epelde I, et al. Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial. J Cachexia Sarcopenia Muscle. 2022;13(2):884-93. doi: 10.1002/jcsm.12925.
49. Martínez-Velilla N, Sáez de Asteasu ML, Ramírez-Vélez R, Zambom-Ferraresi F, García-Hermoso A, Izquierdo M. Recovery of the Decline in Activities of Daily Living After Hospitalization Through an Individualized Exercise Program: Secondary Analysis of a Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2021;76(8):1519-23. doi: 10.1093/gerona/glab032.
© Serdi 2022